HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Karl-Jürgen Bär Selected Research

Pain (Aches)

8/2013Neuronal prostaglandin E2 receptor subtype EP3 mediates antinociception during inflammation.
4/2013Thresholds and perception of cold pain, heat pain, and the thermal grill illusion in patients with major depressive disorder.
3/2012Acupuncture--deep pain with an autonomic dimension?
2/2011Pseudohypoalgesia on the skin: a novel view on the paradox of pain perception in depression.
5/2010Spinal tumor necrosis factor alpha neutralization reduces peripheral inflammation and hyperalgesia and suppresses autonomic responses in experimental arthritis: a role for spinal tumor necrosis factor alpha during induction and maintenance of peripheral inflammation.
5/2010Increased sensitivity to heat pain after sad mood induction in female patients with major depression.
10/2007Decreased sensitivity to thermal pain in rats bred for high anxiety-related behaviour is attenuated by citalopram or diazepam treatment.
6/2006Influence of antipsychotic medication on pain perception in schizophrenia.
7/2005Painful hallucinations and somatic delusions in a patient with the possible diagnosis of neuroborreliosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Karl-Jürgen Bär Research Topics

Disease

12Schizophrenia (Dementia Praecox)
03/2022 - 06/2006
9Pain (Aches)
08/2013 - 07/2005
3Inflammation (Inflammations)
08/2013 - 01/2004
2Anorexia Nervosa
01/2021 - 12/2010
2Alzheimer Disease (Alzheimer's Disease)
06/2015 - 12/2007
2Cardiac Arrhythmias (Arrythmia)
12/2010 - 10/2009
2Arthritis (Polyarthritis)
05/2010 - 05/2004
2Hyperalgesia
05/2010 - 05/2004
1Sleep Deprivation
01/2021
1Mental Disorders (Mental Disorder)
07/2020
1Borderline Personality Disorder (Personality Disorders, Borderline)
01/2018
1Acute Pain
12/2017
1Paranoid Schizophrenia (Delusional Disorder)
02/2015
1Treatment-Resistant Depressive Disorder
01/2013
1Myocardial Infarction
05/2012
1Death (Near-Death Experience)
05/2012
1Nausea
03/2012
1Vomiting
03/2012
1Amyloid Plaque
12/2011
1Hyperemia
07/2011
1Heart Diseases (Heart Disease)
12/2010
1Lung Diseases (Lung Disease)
08/2010
1Major Depressive Disorder (Major Depressive Disorders)
08/2010
1Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
06/2010
1Chronic Pain
05/2010
1Experimental Arthritis
05/2010
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
12/2007
1Cerebral Small Vessel Diseases
12/2007
1Hallucinations (Hallucination)
09/2007
1Obesity
09/2007
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
07/2007
1Panic Disorder (Panic Attack)
01/2007
1Heart Arrest (Cardiac Arrest)
10/2006
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
10/2006
1Multiple Organ Failure (MODS)
10/2006
1Heart Failure
10/2006
1Tachycardia (Tachyarrhythmias)
09/2006
1Fatal Familial Insomnia
11/2002

Drug/Important Bio-Agent (IBA)

5Antipsychotic Agents (Antipsychotics)IBA
08/2013 - 07/2005
3Biomarkers (Surrogate Marker)IBA
01/2021 - 12/2010
3Antidepressive Agents (Antidepressants)IBA
01/2021 - 10/2009
2Neurotransmitter Agents (Neurotransmitter)IBA
01/2019 - 01/2018
2Dinoprostone (PGE2)FDA Link
08/2013 - 01/2004
2Proteins (Proteins, Gene)FDA Link
08/2013 - 05/2004
2AntigensIBA
05/2010 - 05/2004
2ElectrolytesIBA
09/2007 - 07/2007
2Adrenergic Agents (Adrenergic Drugs)IBA
01/2007 - 09/2006
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
03/2022
1EsketamineIBA
01/2021
1KetamineFDA LinkGeneric
01/2021
117-hydroxyestrane-3-carbonitrile (ECN)IBA
01/2021
1gamma-Aminobutyric Acid (GABA)IBA
12/2017
1Retinaldehyde (Retinal)IBA
06/2015
1Calcibiotic Root Canal SealerIBA
02/2015
1Lactic Acid (Lactate)FDA LinkGeneric
09/2013
1Cholinergic Antagonists (Anticholinergics)IBA
08/2013
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
04/2013
1Chlormethiazole (Clomethiazole)IBA
05/2012
1Analgesics (Analgesic Drugs)IBA
03/2012
1PC6 extract (PC6)IBA
03/2012
1Coloring Agents (Dyes)IBA
12/2011
1Duloxetine Hydrochloride (Cymbalta)FDA Link
02/2011
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
12/2010
1Indicators and Reagents (Reagents)IBA
12/2010
1Clostridium perfringens epsilon-toxinIBA
08/2010
1Sertraline (Zoloft)FDA LinkGeneric
06/2010
1Etanercept (Enbrel)FDA Link
05/2010
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2010
1CytokinesIBA
05/2010
1Olanzapine (Zyprexa)FDA Link
12/2008
1EsterasesIBA
12/2007
1Hemoglobins (Hemoglobin)IBA
12/2007
1Acetylcholine (Acetylcholine Chloride)FDA Link
12/2007
1Cholinergic Agents (Cholinergics)IBA
12/2007
1Galantamine (Galanthamine)FDA LinkGeneric
12/2007
1Diazepam (Valium)FDA LinkGeneric
10/2007
1CitalopramFDA LinkGeneric
10/2007
1Anti-Anxiety Agents (Anxiolytics)IBA
10/2007
1PotassiumIBA
07/2007
1Adrenergic beta-Agonists (beta-Adrenergic Agonists)IBA
01/2007
1Isoproterenol (Isoprenaline)FDA LinkGeneric
01/2007
19 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA
06/2006
1TRPV1 receptorIBA
05/2004
1ProstaglandinsIBA
01/2004
1Prion ProteinsIBA
11/2002

Therapy/Procedure

1Exercise Therapy (Therapy, Exercise)
07/2020
1Endurance Training
01/2019
1Vagus Nerve Stimulation
01/2013
1Percutaneous Collagen Induction
03/2012
1Acupuncture Points (Acupuncture Point)
03/2012
1Lasers (Laser)
07/2011
1Length of Stay
10/2006